Roche to launch high-volume SARS-CoV-2 antigen test

Roche plans to launch its high-volume Elecsys SARS-CoV-2 Antigen test at the end of 2020 in markets accepting the CE mark; while the company will file for Emergency Use Authorzsation (EUA) from the U.S. Food and Drug Administration (FDA).